Partial allosteric modulation of GABAA receptor: molecular mechanisms and clinical implications.

Allosteric modulation of GABAA receptors via multiple drug-binding sites.

Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.

Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.

Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor.

Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism-like behaviors in the BTBR mouse model.

Positive allosteric modulation of the GHB high-affinity binding site by the GABAA receptor modulator monastrol and the flavonoid catechin.

Neurobiological Insights from mGlu Receptor Allosteric Modulation.

Alcohol modulation of GABAA receptor function and gene expression.

Zinc and diabetes mellitus: understanding molecular mechanisms and clinical implications.

Caloric restriction and cancer: molecular mechanisms and clinical implications.

HBV DNA Integration: Molecular Mechanisms and Clinical Implications.

Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.

Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2.

GABAA receptor modulation of memory: the role of endogenous benzodiazepines.

Structure and molecular modeling of GABAA receptor antagonists.

Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

Orthosteric- versus allosteric-dependent activation of the GABAA receptor requires numerically distinct subunit level rearrangements.

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor.

Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of α1β3γ2L GABAA Receptors.

Novel positive allosteric modulators of GABAA receptors with anesthetic activity.

Alcoholic Myopathy: Pathophysiologic Mechanisms and Clinical Implications.

Neuropathic pain: mechanisms and their clinical implications.

Suggest Documents

Allosteric modulation of GABAA receptors via multiple drug-binding sites.

Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.

Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.

Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor.

Allosteric modulation of nicotinic and GABAA receptor subtypes differentially modify autism-like behaviors in the BTBR mouse model.

Positive allosteric modulation of the GHB high-affinity binding site by the GABAA receptor modulator monastrol and the flavonoid catechin.

Neurobiological Insights from mGlu Receptor Allosteric Modulation.

Alcohol modulation of GABAA receptor function and gene expression.

Zinc and diabetes mellitus: understanding molecular mechanisms and clinical implications.

Caloric restriction and cancer: molecular mechanisms and clinical implications.

HBV DNA Integration: Molecular Mechanisms and Clinical Implications.

Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.

Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2.

GABAA receptor modulation of memory: the role of endogenous benzodiazepines.

Structure and molecular modeling of GABAA receptor antagonists.

Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

Orthosteric- versus allosteric-dependent activation of the GABAA receptor requires numerically distinct subunit level rearrangements.

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor.

Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of α1β3γ2L GABAA Receptors.

Novel positive allosteric modulators of GABAA receptors with anesthetic activity.

Alcoholic Myopathy: Pathophysiologic Mechanisms and Clinical Implications.

Neuropathic pain: mechanisms and their clinical implications.

Partial allosteric modulation of GABAA receptor: molecular mechanisms and clinical implications.

Recommend Documents

Follow Us